PHARMAC responds on TNF inhibitors for inflammatory arthritis

N Z Med J. 2005 Dec 16;118(1227):U1799.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antirheumatic Agents / economics
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / economics
  • Cost-Benefit Analysis
  • Drug Approval / economics*
  • Drug Evaluation / methods
  • Humans
  • National Health Programs / economics*
  • New Zealand
  • Patient Selection
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha